Japan’s Towa Pharmaceutical has completed its €329m ($364m) deal to acquire the [Pensa Investments] generics business from Spain’s Esteve.
The closure of the deal, through which Pensa has now become a wholly-owned Towa subsidiary, comes just a month after...





